Literature DB >> 18729775

The TRAIL of helpless CD8+ T cells in HIV infection.

Stefanie Kuerten1, Robert J Asaad, Stephen P Schoenberger, Doychin N Angelov, Paul V Lehmann, Magdalena Tary-Lehmann.   

Abstract

Our understanding of how CD4(+) T cells can regulate CD8(+) T cell responses in HIV infection is still incomplete. Recent evidence obtained in mice suggests that CD4(+) T cell help is required for efficient CD8(+) T cell-mediated immunity in chronic infection: CD8(+) T cells primed in the absence of such help release the TNF-related apoptosis-inducing ligand TRAIL and undergo apoptosis. Using a novel ELISPOT assay, in the present study we show that CD8(+) T cells are also a source of the antigen-specific TRAIL response in HIV-infected patients with CD4(+) T cell counts below 200. In patients with CD4(+) T cell counts above 200 TRAIL was not detectable. Accordingly, antigens to which patients have likely been exposed when CD4(+) T cell levels were high (e.g., influenza, CMV, and EBV) did not induce TRAIL. Within the HIV-positive donor population with low CD4(+) T cell counts a dissociation of the interferon-gamma (IFN-gamma) and TRAIL response to different HIV peptide epitopes was detectable suggesting impaired immunity to antigens that triggered TRAIL in the absence of IFN-gamma. Our findings emphasize that "helpless" CD8(+) T cells, i.e., cells that have been primed in the absence of CD4(+) T cell help, may play a crucial role in HIV infection. A "helpless" phenotype may impair CD8(+) T cell control of HIV and other infections and possibly contribute to the depletion of CD4(+) T cells via apoptosis. Immunizations and infections in this "helpless" state might result in ineffective CD8(+) T cell responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18729775      PMCID: PMC2928039          DOI: 10.1089/aid.2008.0062

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  48 in total

1.  Requirement for CD4 T cell help in generating functional CD8 T cell memory.

Authors:  Devon J Shedlock; Hao Shen
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

Review 2.  Towards a cellular definition of CD8+ T-cell memory: the role of CD4+ T-cell help in CD8+ T-cell responses.

Authors:  Benedita Rocha; Corinne Tanchot
Journal:  Curr Opin Immunol       Date:  2004-06       Impact factor: 7.486

3.  Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.

Authors:  Rika Draenert; Marcus Altfeld; Christian Brander; Nesli Basgoz; Colleen Corcoran; Alysse G Wurcel; David R Stone; Spyros A Kalams; Alicja Trocha; Marylyn M Addo; Philip J R Goulder; Bruce D Walker
Journal:  J Immunol Methods       Date:  2003-04-01       Impact factor: 2.303

4.  Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.

Authors:  Eri Ishikawa; Masatoshi Nakazawa; Masahiro Yoshinari; Mutsuhiko Minami
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection.

Authors:  Devon J Shedlock; Jason K Whitmire; Joyce Tan; Andrew S MacDonald; Rafi Ahmed; Hao Shen
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

6.  TNF-related apoptosis-inducing ligand mediates human neuronal apoptosis: links to HIV-1-associated dementia.

Authors:  Lisa A Ryan; Hui Peng; David A Erichsen; Yunlong Huang; Yuri Persidsky; You Zhou; Howard E Gendelman; Jialin Zheng
Journal:  J Neuroimmunol       Date:  2004-03       Impact factor: 3.478

7.  Macrophages from cancer patients: analysis of TRAIL, TRAIL receptors, and colon tumor cell apoptosis.

Authors:  Jean-Philippe Herbeuval; Claude Lambert; Odile Sabido; Michèle Cottier; Pierre Fournel; Michel Dy; Christian Genin
Journal:  J Natl Cancer Inst       Date:  2003-04-16       Impact factor: 13.506

8.  Tc1 effector diversity shows dissociated expression of granzyme B and interferon-gamma in HIV infection.

Authors:  Thomas O Kleen; Robert Asaad; Samuel J Landry; Bernhard O Boehm; Magdalena Tary-Lehmann
Journal:  AIDS       Date:  2004-02-20       Impact factor: 4.177

9.  Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.

Authors:  Jianhong Cao; John McNevin; Sarah Holte; Lisa Fink; Lawrence Corey; M Juliana McElrath
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Defective CD8 T cell memory following acute infection without CD4 T cell help.

Authors:  Joseph C Sun; Michael J Bevan
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

View more
  10 in total

1.  CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions.

Authors:  Peter Dias; Francesca Giannoni; Lian Ni Lee; Dongun Han; Sorah Yoon; Hideo Yagita; Miyuki Azuma; Sally R Sarawar
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

Review 2.  Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response.

Authors:  Robert L Furler; Christel H Uittenbogaart
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

3.  NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.

Authors:  Andrew Zloza; Frederick J Kohlhapp; Gretchen E Lyons; Jason M Schenkel; Tamson V Moore; Andrew T Lacek; Jeremy A O'Sullivan; Vineeth Varanasi; Jesse W Williams; Michael C Jagoda; Emily C Bellavance; Amanda L Marzo; Paul G Thomas; Biljana Zafirova; Bojan Polić; Lena Al-Harthi; Anne I Sperling; José A Guevara-Patiño
Journal:  Nat Med       Date:  2012-02-26       Impact factor: 53.440

4.  TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion.

Authors:  Prajwal Gurung; Tamara A Kucaba; Stephen P Schoenberger; Thomas A Ferguson; Thomas S Griffith
Journal:  J Leukoc Biol       Date:  2010-08-31       Impact factor: 4.962

5.  Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy.

Authors:  Julia Pohling; Katrin Zipperlen; Natasha A Hollett; Maureen E Gallant; Michael D Grant
Journal:  BMC Infect Dis       Date:  2010-05-25       Impact factor: 3.090

Review 6.  Coinfection with HIV-1 and HCV--a one-two punch.

Authors:  Arthur Y Kim; Raymond T Chung
Journal:  Gastroenterology       Date:  2009-06-21       Impact factor: 22.682

Review 7.  Therapeutic applications of TRAIL receptor agonists in cancer and beyond.

Authors:  Gustavo P Amarante-Mendes; Thomas S Griffith
Journal:  Pharmacol Ther       Date:  2015-09-05       Impact factor: 12.310

8.  ELISPOTs Produced by CD8 and CD4 Cells Follow Log Normal Size Distribution Permitting Objective Counting.

Authors:  Alexey Y Karulin; Kinga Karacsony; Wenji Zhang; Oleg S Targoni; Ioana Moldovan; Marcus Dittrich; Srividya Sundararaman; Paul V Lehmann
Journal:  Cells       Date:  2015-01-20       Impact factor: 6.600

9.  High Reproducibility of ELISPOT Counts from Nine Different Laboratories.

Authors:  Srividya Sundararaman; Alexey Y Karulin; Tameem Ansari; Nadine BenHamouda; Judith Gottwein; Sreenivas Laxmanan; Steven M Levine; John T Loffredo; Stephanie McArdle; Christine Neudoerfl; Diana Roen; Karina Silina; Mackenzie Welch; Paul V Lehmann
Journal:  Cells       Date:  2015-01-09       Impact factor: 6.600

Review 10.  The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses.

Authors:  Duygu Sag; Zeynep Ozge Ayyildiz; Sinem Gunalp; Gerhard Wingender
Journal:  Cancers (Basel)       Date:  2019-09-30       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.